bluebird bio reports fourth quarter and full year 2018 financial results
bluebird bio reported total revenues were $54.6 million for the 2018 year end versus $35.4 million for the 2017. Net loss was $555.6 million for the year ended Dec.31, 2018 versus $335.6 million for the 2017 year end. Cash and equivalents as of Dec. 31, 2018 were $1.9 billion. February 21, 2019